CRISPR Therapeutics AG (CRSP) IPO Opens Up 7%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. AXP
6. T
7. TMUS
8. BRO
9. SPY
10. CVS

Go back to CRISPR Therapeutics AG (CRSP) IPO Opens Up 7%

CRISPR Therapeutics Announces Pricing of Initial Public Offering

October 18, 2016 10:00 PM EDT

BASEL, Switzerland and CAMBRIDGE, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq: CRSP), a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into transformative medicines, today announced the pricing of its initial public offering of 4,000,000 common shares at a public offering price of $14.00 per share. In addition, CRISPR Therapeutics has granted the underwriters a 30-day option to purchase up to 600,000 additional common shares at the initial public offering price, less the underwriting discounts and commissions. CRISPR Therapeutics common shares are expected to begin trading on the NASDAQ Global Market under the ticker symbol CRSP... More